ClinicalTrials.gg

Program

Abatacept

Also written as “Belatacept”, “abatacept” and “Abatacept (BMS-188667)”.

Its studies are mostly in Arthritis, Rheumatoid · Arthritis, Juvenile · Psoriasis · Arthritis, Psoriatic · Lupus Nephritis, led by 3 companies.

Furthest: phase 4, since Dec 19, 201268 company-led studies, 2 open or runningNext primary completion: Dec 30, 2032 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Bristol-Myers Squibb652 open or runningphase 4since Dec 19, 2012May 3, 2002Dec 30, 2032phase 3 · NCT04877288
Simcere Pharmaceutical Group20 open or runningphase 3since Mar 10, 2016Mar 10, 2016none ahead
Amneal Pharmaceuticals10 open or runningphase 1since Jan 31, 2025Jan 31, 2025none ahead

Also a collaborator on its studies: Ono Pharmaceutical.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 45 studies since Jun 30, 2005.

  1. May 12, 2014Phase 2 study in Kidney TransplantationBristol-Myers Squibb · NCT02137239 · 58 enrolled · United States, Argentina
  2. Jul 20, 2015Phase 3 study in Arthritis, RheumatoidBristol-Myers Squibb · NCT02504268 · 994 enrolled · United States, Argentina, Australia and more
  3. Oct 29, 2015Phase 2 study in Nephrotic SyndromeBristol-Myers Squibb · NCT02592798 · 36 enrolled · United States
  4. Mar 10, 2016Simcere Pharmaceutical Group's first study: phase 3 study in Arthritis, RheumatoidNew to Simcere Pharmaceutical GroupSimcere Pharmaceutical Group · NCT02722694 · 360 enrolled · China
  5. Jun 12, 2016Phase 1 study in Arthritis, RheumatoidSimcere Pharmaceutical Group · NCT02805010 · 22 enrolled
  6. Sep 23, 2016Phase 3 study in Sjogrens DiseaseBristol-Myers Squibb · NCT02915159 · 250 enrolled · United States, Argentina, Australia and more
  7. Jun 14, 2017Phase 3 study in Giant Cell ArteritisBristol-Myers Squibb · NCT03192969 · United States, Australia, Austria and more
  8. Dec 13, 2017Phase 1 study in Healthy VolunteersBristol-Myers Squibb · NCT03375138 · 84 enrolled · United States
  9. Oct 18, 2018Phase 1 study in Arthritis, RheumatoidBristol-Myers Squibb · NCT03714022 · 140 enrolled · United States
  10. Nov 28, 2019Phase 2 study in Autoimmune DiseasesBristol-Myers Squibb · NCT04186871 · 119 enrolled · United States, Argentina, Belgium and more
  11. Jul 14, 2020Phase 2 study in COVID-19Bristol-Myers Squibb · NCT04472494 · 61 enrolled · United States, Puerto Rico
  12. May 3, 20212 phase 3 studiesBristol-Myers Squibb · NCT04877288, NCT04909801
  13. Aug 1, 2023Phase 1 study in Healthy ParticipantsBristol-Myers Squibb · NCT05981976 · 174 enrolled · United States
  14. Jan 31, 2025Amneal Pharmaceuticals's first study: phase 1 study in Arthritis, RheumatoidNew to Amneal PharmaceuticalsAmneal Pharmaceuticals · NCT06929039 · 300 enrolled · Canada

Ahead

  1. Dec 30, 2032Primary completion: phase 3 study in Renal Allograft RecipientsBristol-Myers Squibb · NCT04877288

TargetBeta

CD80 →CD86 →read by rule
“T-lymphocyte activation antigen CD86 inhibitor; T-lymphocyte activation antigen CD80 inhibitor”ChEMBL 37, by rule

Studies

The newest 60 of 68 led by companies developing it. Each opens its study page. Every study on its drug page →

StudyPhaseStatusLed byPrimary completionSize
NCT06929039Arthritis, Rheumatoid · Canada1CompletedAmneal PharmaceuticalsOct 16, 2024300
NCT05981976Healthy Participants · United States1CompletedBristol-Myers SquibbDec 14, 2023174
NCT04909801Arthritis, Rheumatoid · United States, Argentina, Australia and more3Active, not recruitingBristol-Myers SquibbJun 14, 2023338
NCT04877288Renal Allograft Recipients · United States, Argentina, Belgium and more3RecruitingBristol-Myers SquibbDec 30, 2032102
NCT04472494COVID-19 · United States, Puerto Rico2TerminatedBristol-Myers SquibbAug 12, 202161
NCT04186871Autoimmune Diseases · United States, Argentina, Belgium and more2CompletedBristol-Myers SquibbDec 5, 2022119
NCT03714022Arthritis, Rheumatoid · United States1CompletedBristol-Myers SquibbApr 2, 2019140
NCT03375138Healthy Volunteers · United States1CompletedBristol-Myers SquibbMay 8, 201884
NCT03192969Giant Cell Arteritis · United States, Australia, Austria and more3WithdrawnBristol-Myers SquibbJun 7, 20200
NCT02915159Sjogrens Disease · United States, Argentina, Australia and more3CompletedBristol-Myers SquibbAug 7, 2018250
NCT02805010Arthritis, Rheumatoid1UNKNOWNSimcere Pharmaceutical GroupFeb 201722
NCT02722694Arthritis, Rheumatoid · China3UNKNOWNSimcere Pharmaceutical GroupJun 2017360
NCT02592798Nephrotic Syndrome · United States2CompletedBristol-Myers SquibbJan 28, 202036
NCT02504268Arthritis, Rheumatoid · United States, Argentina, Australia and more3CompletedBristol-Myers SquibbJan 16, 2017994
NCT02137239Kidney Transplantation · United States, Argentina2CompletedBristol-Myers SquibbMay 2, 201958
NCT01890473Arthritis, Rheumatoid · United States, Argentina, Mexico and more1CompletedBristol-Myers SquibbNov 2014356
NCT01860976Arthritis, Psoriatic · United States, Argentina, Brazil and more3CompletedBristol-Myers SquibbJul 14, 2015489
NCT01844518Active Polyarticular Juvenile Idiopathic Arthritis · United States, Argentina, Belgium and more3CompletedBristol-Myers SquibbMar 12, 2015219
NCT01835470Arthritis, Juvenile · Japan3CompletedBristol-Myers SquibbNov 24, 201523
NCT01844895Arthritis, Rheumatoid3CompletedBristol-Myers SquibbJul 2014120
NCT01820572Kidney Transplantation · United States, Argentina, Austria and more3CompletedBristol-Myers SquibbOct 24, 2019446
NCT01791491Kidney Transplant · United States2CompletedBristol-Myers SquibbDec 6, 201616
NCT01766050Transplant Rejection · United States4CompletedBristol-Myers SquibbApr 201345
NCT01758198Arthritis, Rheumatoid · Japan4CompletedBristol-Myers SquibbDec 26, 2016405
NCT01714817Lupus Nephritis · United States, Argentina, Australia and more3TerminatedBristol-Myers SquibbNov 21, 2016695
NCT01439204Arthritis, Rheumatoid · United States1CompletedBristol-Myers SquibbFeb 2012223
NCT01221636Arthritis, Rheumatoid · United States1WithdrawnBristol-Myers SquibbFeb 20110
NCT01142726Arthritis, Rheumatoid · United States, Australia, Belgium and more3CompletedBristol-Myers SquibbSep 2013511
NCT00989235Arthritis, Rheumatoid3CompletedBristol-Myers SquibbOct 2009108
NCT00929864Arthritis, Rheumatoid · United States, Argentina, Canada and more3CompletedBristol-Myers SquibbOct 2011869
NCT00767325Arthritis, Rheumatoid · Denmark, France, Germany and more3CompletedBristol-Myers SquibbOct 2011104
NCT00705367Lupus Nephritis · China1CompletedBristol-Myers SquibbJan 200913
NCT00663702Arthritis, Rheumatoid · United States, Canada, Mexico3CompletedBristol-Myers SquibbDec 2009123
NCT00578448Renal Transplantation · United States, Argentina, Mexico2CompletedBristol-Myers SquibbMar 200914
NCT00569803Transplantation · United States1CompletedBristol-Myers SquibbAug 2008153
NCT00559585Arthritis, Rheumatoid · United States, Argentina, Australia and more3CompletedBristol-Myers SquibbNov 20092,492
NCT00547521Arthritis, Rheumatoid · United States, Australia, Mexico and more3CompletedBristol-Myers SquibbDec 2008119
NCT00534313Arthritis, Psoriatic · United States, Argentina, Australia and more2TerminatedBristol-Myers SquibbDec 2008191
NCT00533897Arthritis, Rheumatoid · United States, Argentina, Canada and more3CompletedBristol-Myers SquibbDec 2008270
NCT00484289Arthritis, Rheumatoid · Japan3CompletedBristol-Myers SquibbDec 2010217
NCT00455013Disorder Related to Renal Transplantation · United States, Italy, Spain2CompletedBristol-Myers SquibbOct 200893
NCT00430677Lupus Erythematosus, Systemic · United States, Argentina, Australia and more3TerminatedBristol-Myers SquibbSep 2010423
NCT00420199Active Rheumatoid Arthritis · Belgium, Germany, Netherlands and more3CompletedBristol-Myers SquibbAug 200950
NCT00410410Colitis, Ulcerative · United States, Australia, Belgium and more3CompletedBristol-Myers SquibbJun 2009591
NCT00409838Arthritis, Rheumatoid · Korea, Republic of3CompletedBristol-Myers SquibbJul 2008113
NCT00406653Crohn Disease · United States, Australia, Belgium and more3TerminatedBristol-Myers SquibbNov 2009451
NCT00402168Renal Transplant · United States, Argentina, Australia and more2CompletedBristol-Myers SquibbJun 2009173
NCT00345748Arthritis, Rheumatoid · Japan2CompletedBristol-Myers SquibbNov 2007194
NCT00306878Psoriasis Vulgaris · United States1CompletedBristol-Myers SquibbMay 199745
NCT00287547Psoriasis Vulgaris · United States2CompletedBristol-Myers SquibbJan 1998144
NCT00279734Arthritis, Rheumatoid · United States1CompletedBristol-Myers SquibbJan 200580
NCT00277225Psoriasis Vulgaris · United States1CompletedBristol-Myers SquibbJun 199632
NCT00277199Healthy Subjects · United Kingdom1CompletedBristol-Myers SquibbDec 200230
NCT00254293Arthritis, Rheumatoid · United States2CompletedBristol-Myers SquibbMay 200787
NCT00162279Arthritis, Rheumatoid · United States2CompletedBristol-Myers SquibbFeb 2007141
NCT00162266Arthritis, Rheumatoid · United States, Argentina, Australia and more2CompletedBristol-Myers SquibbSep 2009524
NCT00162201Arthritis, Rheumatoid · United Kingdom1CompletedBristol-Myers SquibbApr 200516
NCT00122382Arthritis, Rheumatoid · United States, Australia, Belgium and more3CompletedBristol-Myers SquibbFeb 20081,052
NCT00124982Arthritis, Rheumatoid · United States, Belgium, Czech Republic and more3CompletedBristol-Myers SquibbAug 20091,286
NCT00124449Arthritis, Rheumatoid · United States, Australia, Belgium and more2CompletedBristol-Myers SquibbMay 200756

How it is read

Names in the registry

  • “Abatacept”, 53 entries
  • “Belatacept”, 9 entries
  • “abatacept”, 4 entries
  • “Abatacept (BMS-188667)”, 4 entries
  • “belatacept”, 2 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.